A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial
ContributorsHuttner, Benedikt![orcid](assets/images/orcid.png)
; de Lastours, V; Wassenberg, M; Maharshak, N; Mauris, Anne; Galperine, Tatiana Katerina; Zanichelli, Veronica; Kapel, N; Bellanger, A; Olearo, Flaminia; Duval, X; Armand-Lefevre, L; Carmeli, Y; Bonten, M; Fantin, B; Harbarth, Stéphan Juergen![orcid](assets/images/orcid.png)
; R-Gnosis WP3 study group
![orcid](assets/images/orcid.png)
![orcid](assets/images/orcid.png)
Published inClinical microbiology and infection, vol. 25, no. 7, p. 830-838
Publication date2019-07
First online date2019-01-04
Abstract
Keywords
- Carbapenemase
- Colistin
- Extended-spectrum β-lactamase
- Faecal microbiota transplantation
- Neomycin
- Administration, Oral
- Aged
- Anti-Bacterial Agents / therapeutic use
- Carbapenem-Resistant Enterobacteriaceae / drug effects
- Carrier State / drug therapy
- Carrier State / microbiology
- Colistin / therapeutic use
- Drug Administration Schedule
- Drug Resistance, Multiple, Bacterial
- Enterobacteriaceae Infections / drug therapy
- Fecal Microbiota Transplantation
- Feces / microbiology
- Female
- Humans
- Male
- Middle Aged
- Tertiary Care Centers
- beta-Lactamases
Affiliation
Funding
- European Commission - Resistance in Gram-Negative Organisms: Studying Intervention Strategies [282512]
Citation (ISO format)
HUTTNER, Benedikt et al. A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant <i>Enterobacteriaceae</i>: a randomized clinical trial. In: Clinical microbiology and infection, 2019, vol. 25, n° 7, p. 830–838. doi: 10.1016/j.cmi.2018.12.009
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
- PID : unige:158998
- DOI : 10.1016/j.cmi.2018.12.009
- PMID : 30616014
ISSN of the journal1198-743X